Similar to our findings, silencing PARD3 was found to lead to a defect in glioma sphere formation in vitro, suggesting that the self-renewal capacity of TICs was lost upon PARD3 silencing [41]. This evidence concerns the gene PARD3 and central nervous system cancer.